The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

The executive order directs Trump's administration to take actions against "discriminatory" policies in foreign countries ...

The executive order directs Trump's administration to take actions against "discriminatory" policies in foreign countries ...

Unlike Trump's first term, his proposed "most favored nation" policy, tying U.S. drug prices to the lowest prices paid by ...

Trump signed a similar executive order in the final weeks of his first term, but a court order later blocked the rule from ...

U.S. President Donald Trump signed a broad executive order on Monday directing drugmakers to lower the prices of their ...

Trump asks the drug industry to voluntarily lower prices for U.S. consumers or be subject to a barrage of regulatory actions ...

A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the ...

President Trump signed an executive order Monday that will attempt to bring the down the cost of some drugs in the United States — but why are drugs so high to begin with?

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

Medicare seeks public comments as the agency plans to list up to 15 additional drugs selected for the third round of pricing ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...